Single Arm Phase II Clinical Trial to Investigate the Efficacy and Safety of Apatinib as a Single Agent in Advanced Non-squamous Non-small Cell Lung Cancer Patients Who Failed to Previous at Least 3rd Line Treatments.

Trial Profile

Single Arm Phase II Clinical Trial to Investigate the Efficacy and Safety of Apatinib as a Single Agent in Advanced Non-squamous Non-small Cell Lung Cancer Patients Who Failed to Previous at Least 3rd Line Treatments.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Aug 2015

At a glance

  • Drugs Apatinib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top